Center for Scientific Review; Notice of Closed Meetings, 18317-18318 [2018-08721]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 81 / Thursday, April 26, 2018 / Notices
has been finalized. All agenda items are
tentative and subject to change.
Public attendance at the meeting is
limited to the available space.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Advisory Council at the
address/telephone number listed above
at least one week prior to the meeting.
For those unable to attend in person, a
live webcast will be available. More
information on registration and
accessing the webcast can be found at
https://www.hhs.gov/ash/carb/.
Members of the public will have the
opportunity to provide comments prior
to the Advisory Council meeting by
emailing CARB@hhs.gov. Public
comments should be sent in by
midnight May 9, 2018, and should be
limited to no more than one page. All
public comments received prior to May
9, 2018, will be provided to Advisory
Council members; comments are limited
to two minutes per speaker.
Dated: April 19, 2018.
Jomana F. Musmar,
Acting Designated Federal Officer,
Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria Committee
Manager.
[FR Doc. 2018–08803 Filed 4–25–18; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Tick-Borne Disease
Working Group
Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS) announces the
fifth in-person meeting of the TickBorne Disease Working Group (Working
Group) on May 15–16, 2018, from 9:00
a.m. to 7:45 p.m. Eastern Time on May
15 and from 9:00 a.m. to 5:30 p.m.
Eastern Time on May 16. For this fifth
meeting, the Working Group will
provide an overview of the report to the
HHS Secretary and Congress and
discuss what should be included in the
report from the work of the six
Subcommittee Working Groups that
were established on December 12, 2017.
These subcommittees were established
to assist the Working Group with the
development of the report to Congress
and the HHS Secretary as required by
amozie on DSK30RV082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:58 Apr 25, 2018
Jkt 244001
the 21st Century Cures Act. The
subcommittees are:
1. Disease Vectors, Surveillance and
Prevention (includes epidemiology of
tick-borne diseases);
2. Pathogenesis, Transmission, and
Treatment;
3. Testing and Diagnostics (including
laboratory-based diagnoses and clinicaldiagnoses);
4. Access to Care Services and
Support to Patients;
5. Vaccine and Therapeutics; and
6. Other Tick-Borne Diseases and Coinfections.
DATES: May 15, 2018, from 9:00 a.m. to
7:45 p.m. Eastern Time and May 16,
2018, from 9:00 a.m. to 5:30 p.m.
Eastern Time.
ADDRESSES: Hilton Crystal City
Conference Center at Washington
Reagan National Airport, 2399 Jefferson
Davis Highway, Arlington, VA 22202.
Members of the public may also attend
the meeting via webcast. Instructions for
attending the meeting via webcast will
be posted one week prior to the meeting
at: https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/
index.html.
FOR FURTHER INFORMATION CONTACT:
James Berger, Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health,
Department of Health and Human
Services; via email at tickbornedisease@
hhs.gov or by phone at 202–795–7697.
SUPPLEMENTARY INFORMATION:
In-person attendance at the meeting is
limited to space available; therefore,
preregistration for public members is
advisable and can be accomplished by
registering at https://events.r20.
constantcontact.com/register/event?llr=
zz7zptzab&oeidk=a07edrodfu088eae0cf
by Thursday, May 10, 2018. On the day
of the meeting, seating will be provided
first to persons who have preregistered.
People who have not preregistered will
be accommodated on a first come, first
served basis if additional seats are still
available 10 minutes before the meeting
start. Non-U.S. citizens who plan to
attend in person are required to provide
additional information and must notify
the Working Group support staff via
email at tickbornedisease@hhs.gov
before April 30, 2018.
The Working Group invites public
comment on issues related to the
Working Group’s charge. It may be
provided in-person at the meeting or in
writing. In-person comments will occur
from 9:05 a.m. to 10:05 a.m. on May 16,
2018. Persons who wish to provide
public comment in person should
review directions at https://www.hhs.
gov/ash/advisory-committees/
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
18317
tickbornedisease/meetings/
before submitting a request to do so via
email at tickbornedisease@hhs.gov.
Requests to provide in-person comment
are due on or before May 10, 2018. Inperson comments will be limited to
three minutes each to accommodate as
many speakers as possible. If more
requests are received than can be
accommodated, speakers will be
randomly selected. The nature of the
comments will not be considered in
making this selection. Public comments
may also be provided in writing.
Individuals who would like to provide
written comment should review
directions at https://www.hhs.gov/ash/
advisory-committees/tickbornedisease/
meetings/ before sending
their comments to tickbornedisease@
hhs.gov on or before May 10, 2018.
Background and Authority: The TickBorne Disease Working Group was
established on August 10, 2017, in
accordance with section 2062 of the 21st
Century Cures Act, and the Federal
Advisory Committee Act, 5 U.S.C. App.,
as amended, to provide expertise and
review all HHS efforts related to tickborne diseases to help ensure
interagency coordination and minimize
overlap, examine research priorities,
and identify and address unmet needs.
In addition, the Working Group will
report to the Secretary and Congress on
their findings and any recommendations
for the federal response to tick-borne
disease prevention, treatment and
research, and addressing gaps in those
areas.
Dated: April 19, 2018.
James Berger,
Alternate Designated Federal Officer, Office
of HIV/AIDS and Infectious Disease Policy,
Tick-Borne Disease Working Group.
[FR Doc. 2018–08786 Filed 4–25–18; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\26APN1.SGM
26APN1
18318
Federal Register / Vol. 83, No. 81 / Thursday, April 26, 2018 / Notices
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Fogarty Global Brain Disorders 3.
Date: April 20–25, 2018.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, nadis@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Fogarty Global Brain Disorders 2.
Date: April 20–25, 2018.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, nadis@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 20, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–08721 Filed 4–25–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
amozie on DSK30RV082PROD with NOTICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
National Advisory Neurological
Disorders and Stroke Council.
VerDate Sep<11>2014
16:58 Apr 25, 2018
Jkt 244001
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: May 24, 2018.
Open: May 24, 2018, 8:00 a.m. to 2:30 p.m.
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Activities; Administrative and
Program Developments; and Overview of the
NINDS Intramural Program.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Closed: May 24, 2018, 2:30 p.m. to 4:30
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Closed: May 24, 2018, 4:30 p.m. to 5:00
p.m.
Agenda: To review and evaluate the
Division of Intramural Research Board of
Scientific Counselors’ Reports.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Robert Finkelstein, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into Federal buildings. Visitors will be asked
to show one form of identification (for
example, a government-issued photo ID,
driver’s license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: April 20, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–08717 Filed 4–25–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Complementary and
Integrative Health.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Complementary and Integrative
Health.
Date: June 1, 2018.
Closed: 8:30 a.m. to 10:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Conference Room 10, 31 Center
Drive, Bethesda, MD 20892.
Open: 10:15 a.m. to 3:30 p.m.
Agenda: A report from the Institute Acting
Director and Other Staff.
Place: National Institutes of Health,
Building 31, Conference Room 10, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Partap Singh Khalsa,
Ph.D., DC, Director, Division of Extramural
Activities, National Center for
Complementary and Integrative Health, NIH,
National Institutes of Health, 6707
E:\FR\FM\26APN1.SGM
26APN1
]]>Agencies
[Federal Register Volume 83, Number 81 (Thursday, April 26, 2018)]
[Notices]
[Pages 18317-18318]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-08721]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material,
[[Page 18318]]
and personal information concerning individuals associated with the
grant applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Fogarty Global Brain Disorders 3.
Date: April 20-25, 2018.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD 20892, 301-435-
1259, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Fogarty Global Brain Disorders 2.
Date: April 20-25, 2018.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD 20892, 301-435-
1259, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: April 20, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-08721 Filed 4-25-18; 8:45 am]
BILLING CODE 4140-01-P
